ACLARION, INC. Diluted Shares Outstanding (Weighted Average)
ACLARION, INC. (ACON) reported Diluted Shares Outstanding (Weighted Average) of 2.46 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- ACLARION, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 2.46M shares, a 322.80% increase year-over-year.
- ACLARION, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 2.13M shares, a 870.92% increase year-over-year.
- ACLARION, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 744.12K shares, a 60943.56% increase year-over-year.
- ACLARION, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 582.37K shares, a 55736.15% increase year-over-year.
- ACLARION, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 532.04K shares, a 56319.51% increase from fiscal 2024.
- ACLARION, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 943.00 shares, a 1420.97% increase from fiscal 2023.
- ACLARION, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 62.00 shares, a 99.98% decline from fiscal 2022.
- ACLARION, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 381.60K shares, a 57.87% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.46M shares 10-Q · filed 2026-08-06 | 2.30M shares 10-Q · filed 2026-08-06 | 1.78M shares derived: average of 3 quarters · filed 2026-08-06 | 1.48M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 2.13M shares 10-Q · filed 2026-05-13 | 1.44M shares derived: average of 2 quarters · filed 2026-05-13 | 1.15M shares derived: average of 3 quarters · filed 2026-05-13 | 1.01M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 744.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 663.25K shares derived: average of 2 quarters · filed 2026-03-18 | 636.29K shares derived: average of 3 quarters · filed 2026-08-06 | 532.04K shares 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | 582.37K shares 10-Q · filed 2025-11-12 | 582.37K shares derived: average of 2 quarters · filed 2026-08-06 | 461.34K shares 10-Q · filed 2025-11-12 | 346.33K shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 582.37K shares 10-Q · filed 2026-08-06 | 400.87K shares 10-Q · filed 2026-08-06 | 267.65K shares derived: average of 3 quarters · filed 2026-08-06 | 201.00K shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 219.37K shares 10-Q · filed 2026-05-13 | 110.29K shares derived: average of 2 quarters · filed 2026-05-13 | 73.88K shares derived: average of 3 quarters · filed 2026-05-13 | 55.63K shares derived: average of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | 1.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 1.13K shares derived: average of 2 quarters · filed 2026-03-18 | 1.06K shares derived: average of 3 quarters · filed 2026-03-18 | 943.00 shares 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | 1.04K shares 10-Q · filed 2025-11-12 | 9.44M shares 10-Q · filed 2024-11-14 | 975.50 shares derived: average of 2 quarters · filed 2025-11-12 | 851.00 shares 10-Q · filed 2025-11-12 | 7.70M shares 10-Q · filed 2024-11-14 | -386.28K shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 908.00 shares 10-Q · filed 2025-08-14 | 8.22M shares 10-Q · filed 2024-08-14 | 755.00 shares 10-Q · filed 2025-08-14 | 6.83M shares 10-Q · filed 2024-08-14 | -515.39K shares derived: average of 3 quarters · filed 2025-08-14 | -253.31K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 602.00 shares 10-Q · filed 2025-05-15 | 5.44M shares 10-Q · filed 2024-05-15 | -773.54K shares derived: average of 2 quarters · filed 2025-05-15 | -338.05K shares derived: average of 3 quarters · filed 2025-05-15 | -124.04K shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -1.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | -507.37K shares derived: average of 2 quarters · filed 2025-04-09 | -165.59K shares derived: average of 3 quarters · filed 2025-04-09 | 62.00 shares 10-K · filed 2025-04-09 | 556.81K shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 532.93K shares 10-Q · filed 2024-11-14 | 8.53M shares 10-Q · filed 2023-11-14 | 525.45K shares derived: average of 2 quarters · filed 2024-11-14 | 515.98K shares 10-Q · filed 2024-11-14 | 8.26M shares 10-Q · filed 2023-11-14 | -3.37M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 517.98K shares 10-Q · filed 2024-08-14 | 8.29M shares 10-Q · filed 2023-08-25 | 507.50K shares 10-Q · filed 2024-08-14 | 8.12M shares 10-Q · filed 2023-08-25 | -4.68M shares derived: average of 3 quarters · filed 2024-08-14 | -1.55M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 496.16K shares 10-Q · filed 2024-05-15 | 7.94M shares 10-Q · filed 2023-07-03 | -7.27M shares derived: average of 2 quarters · filed 2024-05-15 | -2.24M shares derived: average of 3 quarters · filed 2024-05-15 | 274.18K shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -15.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -3.61M shares derived: average of 2 quarters · filed 2024-03-28 | 200.19K shares derived: average of 3 quarters · filed 2024-03-28 | 381.60K shares 10-K · filed 2024-03-28 | 6.11M shares 10-K · filed 2023-02-27 | |||
| 2022-09-30 | 7.82M shares 10-Q · filed 2023-11-14 | 7.82M shares derived: average of 2 quarters · filed 2023-11-14 | 5.52M shares 10-Q · filed 2023-11-14 | 5.52M shares 10-Q · filed 2022-11-14 | 4.36M shares derived: average of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | 7.82M shares 10-Q · filed 2023-08-25 | 4.37M shares 10-Q · filed 2023-08-25 | 3.21M shares derived: average of 3 quarters · filed 2023-08-25 | 2.63M shares derived: average of 4 quarters · filed 2023-08-25 | ||||
| 2022-03-31 | 905.68K shares 10-Q · filed 2023-07-03 | 905.68K shares derived: average of 2 quarters · filed 2023-07-03 | 905.68K shares derived: average of 3 quarters · filed 2023-07-03 | |||||
| 2021-12-31 | 905.68K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | 905.68K shares derived: average of 2 quarters · filed 2023-06-12 | 905.68K shares 10-K/A · filed 2023-06-12 | |||||
| 2021-09-30 | 905.68K shares 10-Q · filed 2022-11-14 | 905.68K shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |